1-[2-O-ACETYL-3,5-DI-O-BENZOYL-4-C-(N-METHYLPIPERAZINYL)-METHYL-BETA-D-XYLOFURANOSYL]-THYMINE
Compound with spectra: 1 NMR
![1-[2-O-ACETYL-3,5-DI-O-BENZOYL-4-C-(N-METHYLPIPERAZINYL)-METHYL-BETA-D-XYLOFURANOSYL]-THYMINE](/api/compound/LqGe2lBj8Qm.png?ph=true&h=300&w=458 "1-[2-O-ACETYL-3,5-DI-O-BENZOYL-4-C-(N-METHYLPIPERAZINYL)-METHYL-BETA-D-XYLOFURANOSYL]-THYMINE")
| SpectraBase Compound ID | LqGe2lBj8Qm |
|---|---|
| InChI | InChI=1S/C32H36N4O8/c1-22-18-36(21-33-28(22)38)29-26(42-23(2)37)27(43-31(40)25-12-8-5-9-13-25)32(44-29,19-35-16-14-34(3)15-17-35)20-41-30(39)24-10-6-4-7-11-24/h4-13,18,21,26-27,29H,14-17,19-20H2,1-3H3/t26-,27-,29-,32-/m0/s1 |
| InChIKey | QWLNULHRCYOKTL-GKDWDKOASA-N |
| Mol Weight | 604.7 g/mol |
| Molecular Formula | C32H36N4O8 |
| Exact Mass | 604.253314 g/mol |
| Enantiomer InChIKey | QWLNULHRCYOKTL-UUEOAETPSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
naphtho[2,3-b]oxirene-1a(2H)-carboxylic acid, 7,7a-dihydro-7a-[(4-methylphenyl)methyl]-2,7-dioxo-, ethyl ester
4,4,8-trimethyl-5-(2-propylpentanoyl)-4,5-dihydro-1H-[1,2]dithiolo[3,4-c]quinoline-1-thione
1-[2',3',4',6'-tetrakis(Acetyloxy)-.beta.-D-glucopyranosyl]-brassenin A
1,3,5-TRIS-(METHYL-5-ACETAMIDO-4,7,8,9-TETRA-O-ACETYL-3,5-DIDEOXY-D-GLYCERO-ALPHA-D-GALACTO-2-NONULOPYRANOSYLTHIOONATE-PROP-2-YNYL)-BENZENE
Bistrimethylsilyl 3.alpha.,18-dihydroxy-5.beta.-androstane-17-one
3-(2'-methyl-6',7',11'-trimethoxyanthra[1',2'-b]furan-8'-yl)propan-2-one
3-TRIMETHYLSILYLOXY-1-BETA,19-EPOXY-1-BETA,19-CYCLO-5-ALPHA-ANDROSTAN-17-ONE
naringin, 8TMS
3beta, 17beta-dihydroxy-17alpha -pregna-4,6-diene-21-carboxylic acid-gamma-lactone.
N-(2-BENZYLAMINO-2-OXOETHYL)-N-BENZYL-6-AMINO-6-DEOXY-1',2,3,3',4,4'-HEXA-O-BENZYL-6'-O-(2-TERT.-BUTOXY-2-OXOETHYL)-SUCROSE
| Title | Journal or Book | Year |
|---|---|---|
| XNA (xylo Nucleic Acid): A Summary and New Derivatives | European Journal of Organic Chemistry | 2005 |